| 000 | 01040 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514010210.0 | ||
| 264 | 0 | _c20020418 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a1462-2416 | ||
| 024 | 7 |
_a10.1517/14622416.2.3.239 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaunders, A M | |
| 245 | 0 | 0 |
_aGene identification in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cAug 2001 |
||
| 300 |
_a239-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xgenetics |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
| 650 | 0 | 4 | _aChromosome Mapping |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPresenilin-1 |
| 650 | 0 | 4 | _aPresenilin-2 |
| 773 | 0 |
_tPharmacogenomics _gvol. 2 _gno. 3 _gp. 239-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14622416.2.3.239 _zAvailable from publisher's website |
| 999 |
_c11458874 _d11458874 |
||